GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Godavari Drugs Ltd (BOM:530317) » Definitions » Cyclically Adjusted Revenue per Share

Godavari Drugs (BOM:530317) Cyclically Adjusted Revenue per Share : ₹164.04 (As of Dec. 2023)


View and export this data going back to 2001. Start your Free Trial

What is Godavari Drugs Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Godavari Drugs's adjusted revenue per share for the three months ended in Dec. 2023 was ₹57.206. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₹164.04 for the trailing ten years ended in Dec. 2023.

During the past 12 months, Godavari Drugs's average Cyclically Adjusted Revenue Growth Rate was 18.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2024-06-06), Godavari Drugs's current stock price is ₹92.47. Godavari Drugs's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was ₹164.04. Godavari Drugs's Cyclically Adjusted PS Ratio of today is 0.56.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Godavari Drugs was 0.78. The lowest was 0.41. And the median was 0.58.


Godavari Drugs Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Godavari Drugs's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Godavari Drugs Cyclically Adjusted Revenue per Share Chart

Godavari Drugs Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 92.02 117.37 143.91

Godavari Drugs Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 138.48 143.91 151.44 157.32 164.04

Competitive Comparison of Godavari Drugs's Cyclically Adjusted Revenue per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Godavari Drugs's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Godavari Drugs's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Godavari Drugs's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Godavari Drugs's Cyclically Adjusted PS Ratio falls into.



Godavari Drugs Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Godavari Drugs's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=57.206/152.9243*152.9243
=57.206

Current CPI (Dec. 2023) = 152.9243.

Godavari Drugs Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 2.720 91.425 4.550
201406 9.541 94.103 15.505
201409 19.881 96.780 31.414
201412 23.537 96.780 37.191
201503 19.846 97.163 31.236
201506 22.560 99.841 34.555
201509 23.070 101.753 34.672
201512 21.732 102.901 32.297
201603 27.233 102.518 40.623
201606 29.591 105.961 42.706
201609 27.118 105.961 39.137
201612 20.928 105.196 30.423
201703 21.296 105.196 30.958
201706 16.115 107.109 23.008
201709 23.386 109.021 32.804
201712 19.138 109.404 26.751
201803 27.493 109.786 38.296
201806 21.447 111.317 29.463
201809 23.781 115.142 31.584
201812 30.535 115.142 40.555
201903 32.553 118.202 42.116
201906 29.339 120.880 37.117
201909 30.535 123.175 37.910
201912 34.511 126.235 41.807
202003 32.833 124.705 40.263
202006 34.129 127.000 41.096
202009 40.981 130.118 48.164
202012 43.910 130.889 51.302
202103 43.834 131.771 50.871
202106 58.920 134.084 67.199
202109 51.289 135.847 57.737
202112 44.848 138.161 49.640
202203 59.033 138.822 65.030
202206 56.335 142.347 60.521
202209 53.976 144.661 57.059
202212 52.086 145.763 54.645
202303 49.707 146.865 51.758
202306 47.200 150.280 48.030
202309 52.674 151.492 53.172
202312 57.206 152.924 57.206

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Godavari Drugs  (BOM:530317) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Godavari Drugs's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=92.47/164.04
=0.56

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Godavari Drugs was 0.78. The lowest was 0.41. And the median was 0.58.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Godavari Drugs Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Godavari Drugs's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Godavari Drugs (BOM:530317) Business Description

Industry
Traded in Other Exchanges
N/A
Address
Sardar Patel Road, 1-8-303/34, Mayfair, 1st Floor, Secunderabad, TG, IND, 500 003
Godavari Drugs Ltd is an India-based pharmaceutical company. It is principally engaged in the business activity of manufacturing pharmaceutical drugs. The firm's product includes Ciprofloxacin Lactate IH, A D Lactone, Ciprofloxacin Betaine, Enrofloxacin USP/EP/BP/IP, and Others. The company operates only one segment which is the manufacture and sale of Active Pharmaceutical Ingredients (API) and its intermediates.

Godavari Drugs (BOM:530317) Headlines

No Headlines